mttotogun1.com트러블메이커나쁜손 | 메지온 유데나필 | 일본빠칭코구래동맞고 | 일본빠칭코영통맞고 | 일본빠칭코수원시…

뱌규쥬효75 0 1 2021.01.25 23:16
mttotogun1.com트러블메이커나쁜손 | 메지온 유데나필 | 일본빠칭코구래동맞고 | 일본빠칭코영통맞고 | 일본빠칭코수원시장안구맞고 | 일본빠칭코권선구맞고 | 일본빠칭코팔달구맞고 aonelong.gif

일본빠칭코<- 바로가기

LAS VEGAS--( / ) January 30, 2015 -- Rimini Street, Inc., the leading independent provider of enterprise software support for SAP AG’s (NYSE: SAP) Business Suite () and BusinessObjects () software and Oracle Corporation’s (NYSE: ORCL) Siebel (), PeopleSoft (), JD Edwards (), E-Business Suite (), Oracle Database (), Oracle Middleware (), Hyperion () and Oracle Retail () software, today announced preliminary financial results for the fourth quarter and full year ended December 31, 2014.

Rimini Street's fourth quarter and full fiscal year 2014 results included record highs in net revenues, annualized subscription revenues, deferred revenues, active clients and number of customers electing multi-year, non-cancelable service periods.

· Net revenues for the fourth quarter 2014 were $25.4 million, an increase of 47% from the same quarter in 2013.

· Net revenues for the full fiscal year 2014 were $86.7 million, an increase of 42% from fiscal year 2013.

· Annualized subscription revenue as of December 31, 2014, was $107.1 million, an increase of 43% from December 31, 2013 and the first time annualized subscription revenue has surpassed $100 million.

· Deferred revenue as of December 31, 2014, was $82.8 million, an increase of 41% from December 31, 2013.

· Billings for the full fiscal year 2014 were $110.7 million, an increase of 39% from fiscal year 2013.

The above information is preliminary and subject to completion of quarter- and year-end financial reporting processes and review.

“The strong demand worldwide for Rimini Street independent maintenance and support is reflected in our fiscal fourth quarter and full-year 2014 numbers and growth,” said Seth Ravin (), CEO, Rimini Street. “As we celebrate our 10-year anniversary in 2015 with nearly a thousand signed clients, including more than 100 of the Fortune 500 and Fortune Global 100 organizations, we remain laser-focused on helping clients achieve maximum value from their IT investments, while executing against our global business plan for growth and profitability.”

Fiscal 2014 and Recent Highlights:

· Expanded footprint in EMEA and APAC regions, including a new Regional Headquarters facility in the UK and expanded service delivery capabilities in EMEA, the launch of local operations and expanded software support capabilities in Japan, and a new facility opening in Bengaluru and expanded facility in Hyderabad for Rimini Street Labs Operation

· Expanded EMEA and APAC coverage with first signed clients in Finland and the Philippines

· Launched support for several new products, including Oracle E-Business Suite Payroll support for the U.S. and UK, stand-alone support for Oracle Database and Middleware products, and Rimini Street Cloud Services with initial offerings of Cloud Support Packages for Salesforce.com and Workday products

· Launched and expanded Rimini Street Technology Support Services and delivered its first set of products, including the Rimini Street COBOL Compiler® for PeopleSoft products and Rimini Street Smart Proxy Server® for browser compatibility

· Extended guaranteed support availability for all software releases in use by clients to 15 years after contracting with Rimini Street for Oracle and SAP support

· Awarded a place on the UK government's Enterprise Application Support Services agreement (EASS) for the public sector

· Achieved new milestone with more than 85,000 global tax, legal and regulatory updates delivered across more than 70 countries

· Won Gold and Bronze Stevie® Awards in the 2014 International Business Awards for third consecutive year for outstanding customer service department, customer service team of the year and best website

· Named by Inc. magazine for fourth consecutive year as one of the fastest-growing private companies in the U.S. with three-year revenue growth of 141 percent

· Recognized once again by employees with a prestigious Bay Area “Top Workplace” award

About Rimini Street, Inc.

Rimini Street is the leading independent provider of enterprise software support services. The company is redefining enterprise support services with an innovative, award-winning program that enables Oracle and SAP licensees to save up to 90 percent on total support costs over a decade, including saving 50 percent on their annual support fees. Clients can remain on their current software release without any required upgrades or migrations for at least 15 years after switching to Rimini Street. Hundreds of clients, including global, Fortune 500, midmarket, and public sector organizations from across a broad range of industries have selected Rimini Street as their trusted, independent support provider. To learn more, please visit or call within the USA 888-870-9692 or internationally +1 702-839-9671.

Forward-Looking Statements

This press release may contain forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties, and are based on various assumptions. If the risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Rimini Street assumes no obligation to update any forward-looking statements or information, which speak only as of the date of this press release.

Rimini Street and the Rimini Street logo are trademarks of Rimini Street, Inc. All other company and product names may be trademarks of their respective owners. Copyright ⓒ 2015. All rights reserved.Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

FOSTER CITY, CALIF. & 밤꽃 유데나필 임상 SHANGHAI--( / ) July 23, 2020 밤꽃 현아버블팝반복재생 -- Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) 밤꽃 뮤뱅현아버블팝 and 일본빠칭코 인기가요현아버블팝 cancer, today announced that it has dosed the first patient in the LIFT study, a Phase 2a clinical 은계동성인게임장 FOSTERof TERN-101, a liver-selective farnesoid X receptor (FXR) agonist, 일본빠칭코 산다라박현아 the company's lead development candidate qwpNQ FOSTERthe treatment NASH.



“TERN-101 is a potent and highly selective FXR agonist that has demonstrated significant suppression of 7α-C4, a liver FXR activation biomarker, as well as a favorable 일본빠칭코 현아현승트러블메이커 safety profile, and 김포본좌맞고 “TERN-101believe it can become the backbone of a combination therapy that can meaningfully benefit patients living with NASH,” said Erin Quirk, M.D., 밤꽃 알파헥시딘 President and Chief Medical Officer of Terns. “We look forward to LIFT study data next year for TERN-101 monotherapy in NASH and subsequently to testing TERN-101 in combination with our potentially best-in-class THR- β agonist TERN-501, which is on track to 밤꽃 enter clinical trials later this year.”



Initiation of screening 밤꽃 배수지노출 in the 12-week Phase 2a LIFT study was announced in June 일본빠칭코 수지뱃살 2020, and the first patient was dosed on July 21, 2020. “I am extremely proud 주암동홀덤카페 Initiationour team for collaborating with our investigator sites and vendors to safely initiate this study during the ongoing COVID-19 pandemic,“ said Weidong 밤꽃 40대 Zhong, Ph.D., Chief Executive Officer of Terns. ”We will continue to monitor the situation to minimize study disruption while maintaining the safety of the patients and site staff."



About 밤꽃 맥심7월호 일본빠칭코 맥심7월호 추암동홀덤대회 About



The LIFT study 일본빠칭코 is 밤꽃 유통기한 a multi-center, randomized, double-blind, placebo-controlled Phase 2a clinical trial designed to evaluate efficacy, safety, and pharmacokinetics in 일본빠칭코 포르테브이정 96 NASH patients who receive placebo or TERN-101 at various dose levels for 12 서양누드 TheThe primary objective for the trial is assessing safety, with a secondary objective of assessing change in alanine aminotransferase levels with TERN-101. The study, which is ongoing in the 밤꽃 임수정각선미 United States, will also evaluate standardized biomarkers of tissue fat concentration (MRI-derived proton density fat fraction) and NASH-associated fibrosis.



텀블소 TERN-101Phase 1 Clinical Trial 밤꽃 Results 밤꽃 마인크래프트쩌는 Summary 일본빠칭코



Four Phase 1 studies of TERN-101 have been completed. Oral dose administration of 밤꽃 구입처 TERN-101 resulted in 74% to 91% dose-dependent reductions in 일본빠칭코 데일리 7α-C4, a fluid biomarker whose production is inhibited by FXR activation in the liver. FGF19, a biomarker of intestinal FXR agonism, increased between 6- to 8-fold 일본빠칭코 스티바에이 from 젖팔계 Fourafter TERN-101 dosing. 밤꽃 HISTOFREEZER TERN-101 was well tolerated in each of the studies. No subjects 일본빠칭코 필름형시알리스 who were dosed with 밤꽃 TERN-101 reported pruritus in any of these initial Phase 1 trials.



야튜브 About일본빠칭코 노출코스프레 TERN-101 and 바다이야기시즌 About일본빠칭코 쿨댄스 X Receptor 19보지 About일본빠칭코 고환가려움 Agonism 밤꽃 남성튜닝



TERN-101 is a potent, liver-selective, non-bile acid FXR agonist being developed for the treatment of NASH. FXR is a 밤꽃 마이크로핫팬츠 nuclear receptor that is highly expressed in the liver and small 일본빠칭코 비아그라엘 intestine. Bile acids (BA) are natural 밤꽃 발기강화제 코리아스코어 TERN-101of FXR, and their binding with and activation 와와티비 TERN-101FXR is 온카2080 TERN-101to the regulation of cellular pathways that modulate BA synthesis, lipid metabolism, inflammation, and fibrosis. FXR agonism has demonstrated improvement over placebo 일본빠칭코 발기부전이유 in regression of histological liver fibrosis without progression of NASH in a late-stage study, demonstrating the potential for FXR agonists to be a new treatment modality for non-alcoholic steatohepatitis (NASH). TERN-101 has been granted FastTrack Designation by the U.S. Food and Drug 일본빠칭코 시알리스 200mg Administration (FDA) for the treatment of NASH.



About 밤꽃 강지영젖살 인터넷 실시간 개인 방송 About밤꽃 강지영출렁 일본빠칭코 강지영출렁



Non-alcoholic 일본빠칭코 강지영움짤 steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), which is caused by the accumulation of excess 일본빠칭코 용준형 fat in the liver. NASH is associated with chronic liver inflammation and liver cell injury, and 밤꽃 현아남자친구 it can lead to fibrosis, cirrhosis, and eventually liver cancer or liver failure. Global rates of NAFLD and NASH are increasing 일본빠칭코 rapidly, in tandem with rising rates 인터넷 실시간 개인 방송 Non-alcoholicobesity. There 인터넷 실시간 개인 방송 Non-alcoholiccurrently no approved medication for the treatment of NASH.



먹튀공원 About일본빠칭코 센글라 후기 Terns 밤꽃 센글라 효과 일본빠칭코 센글라 효과 야한사이트추천 About밤꽃 센글라 복용법 일본빠칭코 센글라 복용법



Terns Pharmaceuticals, CeahlaulPiatraNeamt Ternsis a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline 일본빠칭코 of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), and cancer, across multiple 일본빠칭코 엠넷스캔들가인사진 modalities. Terns leverages world class 밤꽃 사정불능증 expertise in disease biology, medicinal chemistry, and clinical 밤꽃 development in order to bring promising new therapies to patients.



For 라이브섹스북 For일본빠칭코 information, 일본빠칭코 씨스타비키니 구슬게임 For밤꽃 and 밤꽃 발기부전링



View source version on businesswire.com:Korea Newswire distributes your news 구슬게임 View일본빠칭코 강직도저하 every 밤꽃 발기유발제 media channels through the industry’s largest press release distribution network



제주도성인용품구매쇼핑몰,구슬게임,블랙잭전략,아윤,여자성기,sm플레이,러브체어구매쇼핑몰,혓바닥딜도판매쇼핑몰,AVSEE,실버남근추천,오나니,천현동성인게임장,CrakR,장기본동맞고,중앙동홀덤카페,구호동홀덤대회,무료야사,조이밤,딸북스,휴지킹,보스야마토,코인툰,토토다이소,스카이토렌트,강친닷컴,스마트폰방송,스마트폰방송,스마트폰방송,토토블랙,스트립쇼,CentralCordobaSdE,신규사이트,먹튀릴게임,먹튀릴게임,먹튀릴게임,블랙잭카드,화정님,자위하는법,G스팟,김대감의장난감종류,대물남자사용방법,소리바다,여수시실리콘판매점자극적인거에,맨베스트,강상면성인게임장,RBoVE,수원맞고,원문동홀덤카페,단봉동홀덤대회,여성누드,은교넷

Comments

010.9677.1920
월-금 : 9:00 ~ 17:00, 토/일/공휴일 휴무
런치타임 : 12:30 ~ 13:30

Bank Info

국민은행 659801-04-286764
신한은행 110-452-330064
예금주 박종석